Literature DB >> 16893478

Oxcarbazepine for self-mutilating bulimic patients.

Táki Athanassios Cordás, Hermano Tavares, Douglas Motta Calderoni, Gabriela Viegas Stump, Rafael Bernardon Ribeiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16893478     DOI： 10.1017/S1461145706006687

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN： 1461-1457            Impact factor:   5.176


× No keyword cloud information.
  4 in total

Review 1.  Role of antiepileptic drugs in the management of eating disorders.

Authors:  Susan L McElroy; Anna I Guerdjikova; Brian Martens; Paul E Keck; Harrison G Pope; James I Hudson
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

2.  Improvement of nonsuicidal self-injury following treatment with antipsychotics possessing strong D1 antagonistic activity: evidence from a report of three cases.

Authors:  Bastian Wollweber; Martin E Keck; Ulrike Schmidt
Journal:  Ther Adv Psychopharmacol       Date:  2015-08

3.  Aggression directed towards others vs. aggression directed towards the self: clinical differences between intermittent explosive disorder and nonsuicidal self-injury.

Authors:  Gustavo C Medeiros; Liliana Seger-Jacob; Anna K Garreto; Hyoun S Kim; Emil F Coccaro; Hermano Tavares
Journal:  Braz J Psychiatry       Date:  2019-03-07       Impact factor: 2.697

4.  Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa.

Authors:  L M Huckins; K Hatzikotoulas; L Southam; L M Thornton; J Steinberg; F Aguilera-McKay; J Treasure; U Schmidt; C Gunasinghe; A Romero; C Curtis; D Rhodes; J Moens; G Kalsi; D Dempster; R Leung; A Keohane; R Burghardt; S Ehrlich; J Hebebrand; A Hinney; A Ludolph; E Walton; P Deloukas; A Hofman; A Palotie; P Palta; F J A van Rooij; K Stirrups; R Adan; C Boni; R Cone; G Dedoussis; E van Furth; F Gonidakis; P Gorwood; J Hudson; J Kaprio; M Kas; A Keski-Rahkonen; K Kiezebrink; G-P Knudsen; M C T Slof-Op 't Landt; M Maj; A M Monteleone; P Monteleone; A H Raevuori; T Reichborn-Kjennerud; F Tozzi; A Tsitsika; A van Elburg; D A Collier; P F Sullivan; G Breen; C M Bulik; E Zeggini
Journal:  Mol Psychiatry       Date:  2017-07-25       Impact factor: 15.992
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.